These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 29320979)

  • 41. Recent Advances in Developing K-Ras Plasma Membrane Localization Inhibitors.
    Ye N; Xu Q; Li W; Wang P; Zhou J
    Curr Top Med Chem; 2019; 19(23):2114-2127. PubMed ID: 31475899
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Inhibitors of DNA topoisomerases].
    Andoh T
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1526-35. PubMed ID: 9309151
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Application of natural products derivatization method in the design of targeted anticancer agents from 2000 to 2018.
    Liu W; Li Q; Hu J; Wang H; Xu F; Bian Q
    Bioorg Med Chem; 2019 Dec; 27(23):115150. PubMed ID: 31635893
    [TBL] [Abstract][Full Text] [Related]  

  • 44. New tricks for an old natural product: discovery of highly potent evodiamine derivatives as novel antitumor agents by systemic structure-activity relationship analysis and biological evaluations.
    Dong G; Wang S; Miao Z; Yao J; Zhang Y; Guo Z; Zhang W; Sheng C
    J Med Chem; 2012 Sep; 55(17):7593-613. PubMed ID: 22867019
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anticancer drug discovery in the future: an evolutionary perspective.
    Ma X; Wang Z
    Drug Discov Today; 2009 Dec; 14(23-24):1136-42. PubMed ID: 19800414
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Camptothecin-7-yl-methanthiole: semisynthesis and biological evaluation.
    Christodoulou MS; Zunino F; Zuco V; Borrelli S; Comi D; Fontana G; Martinelli M; Lorens JB; Evensen L; Sironi M; Pieraccini S; Dalla Via L; Gia OM; Passarella D
    ChemMedChem; 2012 Dec; 7(12):2134-43. PubMed ID: 23086693
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A tale of two tumor targets: topoisomerase I and tubulin. The Wall and Wani contribution to cancer chemotherapy.
    Cragg GM; Newman DJ
    J Nat Prod; 2004 Feb; 67(2):232-44. PubMed ID: 14987065
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multiple Perspectives in Anti-cancer Drug Discovery: From old Targets and Natural Products to Innovative Computational Approaches.
    Speck-Planche A
    Anticancer Agents Med Chem; 2019; 19(2):146-147. PubMed ID: 31298144
    [No Abstract]   [Full Text] [Related]  

  • 49. In silico identification of natural products with anticancer activity using a chemo-structural database of Brazilian biodiversity.
    Galúcio JM; Monteiro EF; de Jesus DA; Costa CH; Siqueira RC; Santos GBD; Lameira J; Costa KSD
    Comput Biol Chem; 2019 Dec; 83():107102. PubMed ID: 31487609
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Natural alkaloids as P-gp inhibitors for multidrug resistance reversal in cancer.
    Joshi P; Vishwakarma RA; Bharate SB
    Eur J Med Chem; 2017 Sep; 138():273-292. PubMed ID: 28675836
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Special Issue: Natural Products: Anticancer and Beyond.
    Cui Q; Yang DH; Chen ZS
    Molecules; 2018 May; 23(6):. PubMed ID: 29882875
    [No Abstract]   [Full Text] [Related]  

  • 52. Metal Complexes of Natural Product Like-compounds with Antitumor Activity.
    Heras BL; Amesty Á; Estévez-Braun A; Hortelano S
    Anticancer Agents Med Chem; 2019; 19(1):48-65. PubMed ID: 29692264
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Natural-derived polyphenols as potential anticancer agents.
    Spatafora C; Tringali C
    Anticancer Agents Med Chem; 2012 Oct; 12(8):902-18. PubMed ID: 22292766
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Natural Products as Clinically Important Enzyme Inhibitors.
    Nile SH
    Comb Chem High Throughput Screen; 2020; 23(9):915-916. PubMed ID: 33357176
    [No Abstract]   [Full Text] [Related]  

  • 55. Anti-cancer glycosidase inhibitors from natural products: a computational and molecular modelling perspective.
    Singh A; Mhlongo N; Soliman ME
    Anticancer Agents Med Chem; 2015; 15(8):933-46. PubMed ID: 25706917
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Editorial (Thematic Issue Role of Heteroaromatics as Anticancer Agents).
    Kaur H
    Anticancer Agents Med Chem; 2016; 16(10):1204. PubMed ID: 27592681
    [No Abstract]   [Full Text] [Related]  

  • 57. Effects of novel diarylpentanoid analogues of curcumin on secretory phospholipase A2 , cyclooxygenases, lipo-oxygenase, and microsomal prostaglandin E synthase-1.
    Ahmad W; Kumolosasi E; Jantan I; Bukhari SN; Jasamai M
    Chem Biol Drug Des; 2014 Jun; 83(6):670-81. PubMed ID: 24406103
    [TBL] [Abstract][Full Text] [Related]  

  • 58. DNA Related Enzymes as Molecular Targets for Antiviral and Antitumoral Chemotherapy. A Natural Overview of the Current Perspectives.
    Garro HA; Pungitore CR
    Curr Drug Targets; 2019; 20(1):70-80. PubMed ID: 29697027
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cytotoxic Natural Products as an Approach Towards the Development of Therapeutic Agents for Precision Medicine.
    Rijo P
    Curr Pharm Des; 2018; 24(36):4205-4206. PubMed ID: 30821216
    [No Abstract]   [Full Text] [Related]  

  • 60. Cytotoxic Lanostanoids from Poria cocos.
    Lai KH; Lu MC; Du YC; El-Shazly M; Wu TY; Hsu YM; Henz A; Yang JC; Backlund A; Chang FR; Wu YC
    J Nat Prod; 2016 Nov; 79(11):2805-2813. PubMed ID: 27808511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.